Patents/Assignees

Biocryst Pharmaceuticals, Inc.

28 patents in portfolio

US11708332utility2023
Human Plasma Kallikrein Inhibitors
0 cites
US11708333utility2023
Human Plasma Kallikrein Inhibitors
0 cites
US11708347utility2023
Substituted Benzofuran, Benzopyrrole, Benzothiophene, and Structurally Related Complement Inhibitors
0 cites
US11685721utility2023
Human Plasma Kallikrein Inhibitors
0 cites
US11661426utility2023
Imidazole-containing Inhibitors of ALK2 Kinase
0 cites
US11618731utility2023
Prodrugs of Kallikrein Inhibitors
0 cites
US11618733utility2023
Crystalline Salts of a Plasma Kallikrein Inhibitor
0 cites
US11559515utility2023
Indole Compounds and Analogues Thereof
0 cites

← PreviousPage 2 of 2